Greenbrook TMS Inc

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

TORONTO , Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024.

GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

TORONTO , Feb. 22, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with  institutional investors for the purchase and sale of 6,000,000 common shares at a purchase price of $0.20 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $1.2 million before deducting placement agent commissions and other estimated offering expenses. The closing of the offering is expected to occur on or about February 26, 2024, subject to the satisfaction of customary closing conditions.

Greenbrook Announces $1.2 Million Registered Direct Offering

Greenbrook TMS (NASDAQ: GBNH ) stock is rocketing higher on Wednesday alongside heavy trading of the operator of mental health services centers' shares this morning. As of this writing, more than 18.9 million shares of GBNH stock have changed hands.

Why Is Greenbrook TMS (GBNH) Stock Up 174% Today?

TORONTO , Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").

GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

TORONTO , Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").

GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

TORONTO , Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately.

GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

TORONTO , Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately.

GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

TORONTO , Dec. 28, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-second amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$5,262,952 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").

GREENBROOK TMS RAISES US$5.3 MILLION IN DEBT FINANCING

TORONTO , Dec. 15, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-first amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$4,015,548.22 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

TORONTO , Nov. 21, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") announced today that the Company has entered into a settlement agreement with the plaintiff regarding the previously-announced breach of contract claim in connection with an approximately $2 million promissory note that was issued to a lender associated with Mr. Benjamin Klein, a seller of Check Five LLC (doing business as "Success TMS"), that the Company acquired in July 2022 (the "Klein Note Action").

Greenbrook TMS Announces Settlement of Ongoing Litigation

Greenbrook TMS Inc. (GBNH) Q3 2023 Earnings Call Transcript

TORONTO , Nov. 2, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the eighteenth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional $2,045,685.28 in senior secured term loans from Madryn under the Credit Facility (the "New Loan").

GREENBROOK TMS RAISES US$2.0 MILLION IN DEBT FINANCING

TORONTO , Oct. 26, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company"), will release its 2023 third quarter operational and financial results after market hours on November 8, 2023. THIRD QUARTER 2023 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Peter Willett, Interim Chief Financial Officer, will host a conference call at 12:00 p.m.

GREENBROOK TMS ANNOUNCES DATES FOR ITS THIRD QUARTER 2023 FINANCIAL RESULTS

TORONTO , Oct. 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced the appointment of Mr. Peter Willett as Interim Chief Financial Officer, effective immediately.

GREENBROOK APPOINTS INTERIM CHIEF FINANCIAL OFFICER

TORONTO , Oct. 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has received an aggregate of US$1.9 million in unsecured subordinated debt financing from certain new investors (the "Investors") through the issuance and sale by the Company to the Investors of US$1.9 million aggregate principal amount of unsecured subordinated convertible promissory notes (the "Subordinated Convertible Notes"). The Subordinated Convertible Notes issued to the Investors are identical to the US$6.25 million aggregate principal amount of Subordinated Convertible Notes issued to, among others, Greybrook Health Inc. and certain affiliates of Madryn Fund Administration, LLC ("Madryn").

GREENBROOK TMS RAISES US$1.9 MILLION IN DEBT FINANCING

Greenbrook TMS Inc. (NASDAQ:GBNH ) Q2 2023 Earnings Conference Call August 15, 2023 10:00 AM ET Company Participants Bill Leonard - President and Chief Executive Officer Erns Loubser - Chief Financial Officer Conference Call Participants David Martin - Bloom Burton Frank Takkinen - Lake Street Capital Operator Welcome to the Greenbrook TMS Inc. Fiscal Year 2023 Q2 Results Conference Call and Webcast. All lines are currently on mute to prevent any background noise.

Greenbrook TMS Inc. (GBNH) Q2 2023 Earnings Call Transcript

TORONTO , Aug. 15, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced the Company entered into a note purchase agreement (the "Note Purchase Agreement") with Greybrook Health Inc. ("Greybrook Health") and certain affiliates of Madryn Fund Administration, LLC ("Madryn") whereby the Company issued and sold $2 million aggregate principal amount of unsecured subordinated convertible promissory notes (the "Subordinated Convertible Notes") to Greybrook Health and certain affiliates of Madryn. The Subordinated Convertible Notes bear interest at a rate consistent with the Company's credit facility with Madryn (the "Madryn Credit Facility") and mature on March 31, 2028, or earlier in the event of a change of control, acceleration of other indebtedness or six (6) months following repayment or refinancing of all loans under the Madryn Credit Facility (the "Madryn Loans").

GREENBROOK TMS OBTAINS ADDITIONAL DEBT FINANCING

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), announced a correction to its press release originally dated August 9, 2023 announcing the release of its operational and financial results for the second quarter 2023. In the original press release, the operational and financial results for the second quarter 2023 were stated to be released after market hours on August 15, 2023. Instead, the correct timing of the release will be after market hours on.

Correction of Notice of Time of Greenbrook TMS Second Quarter 2023 Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2023 second quarter operational and financial results after market hours on August 15, 2023. SECOND QUARTER 2023 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on August 16, 2023 to discuss the financial results for the quarter. Dial in Numbers: Toll Free N.

Greenbrook TMS Announces Dates for Its Second Quarter 2023 Financial Results

TORONTO , Aug. 1, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has received US$2.0 million in debt financing under its Credit Facility (as defined below) agented by Madryn Fund Administration, LLC ("Madryn"), and US$1.0 million in debt financing from Greybrook Health Inc. ("Greybrook Health"), one of the Company's existing significant shareholders (collectively, the "Debt Financing"), in order to manage the company's current liquidity requirements. Madryn Debt Financing The Company announces that it has entered into an amendment (the "Credit Facility Amendment") to its previously-announced credit facility with Madryn (the "Credit Facility"), whereby certain affiliates of Madryn have extended an additional tranche of debt financing to the Company in an aggregate principal amount of US$2.0 million, which was fully-funded at closing (the "New Loan").

GREENBROOK TMS RAISES US$3.0 MILLION IN DEBT FINANCING

TORONTO , July 13, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that the Company has entered into a purchase agreement (the "Agreement") with Alumni Capital LP (the "Investor") that provides equity line financing for sales from time to time of up to approximately $4.4 million  (the "Maximum Commitment Amount") of common shares (the "Common Shares") in the share capital of the Company. The Common Shares will be issued from time to time (the "Purchase Shares") in connection with the delivery of purchase notices (each, a "Purchase Notice") delivered by the Company to the Investor, at variable prices as set forth therein, in accordance with the terms of the Agreement.

GREENBROOK TMS ENTERS INTO EQUITY PURCHASE AGREEMENT

TORONTO, ON , June 23, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the acceptance of Mr. Benjamin Klein's resignation from the board of directors of the Company (the "Board").

GREENBROOK TMS CONFIRMS RESIGNATION OF DIRECTOR

TORONTO , June 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2023 (the "Circular").

GREENBROOK TMS ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS

TORONTO , June 5, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") announced today that the sellers of Check Five LLC (d/b/a "Success TMS") ("Success TMS") have filed a complaint in the Superior Court of the State of Delaware against the Company, TMS NeuroHealth Centers, Inc. ("TMS NeuroHealth Centers") and certain executive officers of the Company (the "Complaint"), concerning alleged disputes arising out of the sale of Success TMS to TMS NeuroHealth Centers which was completed in July 2022. The Complaint alleges claims against the Company and certain of its representatives for contractual fraud, indemnification for breach of certain representations and warranties of the Company contained in the membership interest purchase agreement, and breach of the implied covenant of good faith and fair dealing.

Greenbrook TMS Announces Receipt of Statement of Claim

TORONTO , May 19, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it received notification from The Nasdaq Stock Market LLC ("Nasdaq") on May 15, 2023 that the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market (NASDAQ Listing Rule 5550(a)(2)) as the bid price for the Company's common shares (the "Common Shares") on Nasdaq closed below US$1.00 (the "Minimum Bid Requirement") for 30 consecutive days from March 31, 2023 to May 12, 2023. On May 16, 2023, the Company received a separate notification (together with the Minimum Bid Requirement notification, the "Notifications") from Nasdaq that it was not in compliance with the minimum market value of listed securities requirement (Nasdaq Rule 5550(b)(2)) as the market value of the Common Shares was below US$35 million (the "MVLS Requirement") for 30 consecutive days from April 3, 2023, to May 15, 2023.

News for Greenbrook TMS Inc Stock (GBNH)